April 2010 Volume 6, Issue 4

Volume 6, Issue 4 | April 2010

April 2010

In this Issue

Commentary

Drug Discovery News Placeholder Image

Minimizing the cost effects of false positives in cancer testing

In recent months, controversy has swirled around the proper age at which women should have their first mammograms and Pap smears. Yet even as these questions dominate the headlines, we ought not lose sight of a larger issue that affects the lives of every potential cancer patient, male and female: the emotional and economical costs associated with false positives in cancer testing.
Drug Discovery News Placeholder Image

Primer on boards of directors

Do you know what the board is doing? Does the board know what you are doing?

Editor's Focus

Drug Discovery News Placeholder Image

March marked by many mergers and acquisitions

Our special “March M&A Madness!” cover highlights a busy month of mergers and acquisitions in the pharmaceutical and biotechnology industries.

Global News

Drug Discovery News Placeholder Image

From North Carolina to Norway

The Hamner Institutes for Health Sciences and Oslo Cancer Cluster announce oncology-based partnership
Drug Discovery News Placeholder Image

The art of collaboration

WuXi reaches agreement with J&J Pharmaceutical Research & Development
Drug Discovery News Placeholder Image

Epigenetics evolves in international partnership

CellCentric licenses novel epigenetic discovery program to Takeda
Drug Discovery News Placeholder Image

Enough with the labels

Tecan and ForteBio automate label-free assays for bioprocess and drug discovery applications
Drug Discovery News Placeholder Image

Awkward courtship

After more than a year of wooing OSI unsuccessfully, Astellas goes for hostile bid

Diagnostics

Drug Discovery News Placeholder Image

Seeing green with a hybrid

Quidel Corp. completes $130 million acquisition of Diagnostic Hybrids
Drug Discovery News Placeholder Image

Mining for melanoma

GSK, Abbott partner on molecular diagnostic test to select candidates for skin cancer immunotherapy
Drug Discovery News Placeholder Image

Stanford health experts help develop North Korea’s first drug-resistant tuberculosis diagnostic lab

Stanford University professors have broken new ground by trekking through North Korea to initiate the installation of a diagnostic lab to test drug-resistant tuberculosis
Drug Discovery News Placeholder Image

Seeking immunosimplicity

Diamedix inks distribution pact with Fumouze Diagnostics

Instruments & Informatics

Drug Discovery News Placeholder Image

Supercomputing, one PC at a time

Scripps uses IBM World Community Grid to achieve some breakthrough work on HIV/AIDS
Drug Discovery News Placeholder Image

Computype & Agilent: Linked by labels

Computype partners with Agilent Technologies on launch of new microplate labeler, and with Biosero on storage tube label applicators
Drug Discovery News Placeholder Image

Creating new workflows to improve discovery and development

Efforts focus on creation of new applications for high-resolution platform
Drug Discovery News Placeholder Image

ALA and SBS propose to merge as SLAS

Two top associations seek enhanced opportunities for members, greater global reach and financial and operational efficiencies

Omics & Systems Biology

Drug Discovery News Placeholder Image

Done deal for drug discovery

Asterand completes acquisition of BioSeek, a developer of cell-based disease models
Drug Discovery News Placeholder Image

Companions in companion diagnostics

Roche Molecular Systems collaborates with Merck Sharp & Dohme on developmental test for cancer-related gene mutation
Drug Discovery News Placeholder Image

Liver on their plates

Regulus, GSK to develop HCV therapies
Drug Discovery News Placeholder Image

Prime-and-boost via electroporation yields potential HIV vaccine

First candidate from Profectus-Ichor collaboration set to enter clinic in Q2 2010

Research & Development

Drug Discovery News Placeholder Image

Pain- busting partnership

BMS and Allergan in $413 million deal to develop drug for neuropathic pain
Drug Discovery News Placeholder Image

Small molecules lead to big partnership

UCSF enters into drug discovery agreement with Roche’s Genentech
Drug Discovery News Placeholder Image

One door closes, and another opens

MDS divests Pharma Services business to Ricerca Biosciences
Drug Discovery News Placeholder Image

Breathing easier

Cephalon’s purchase of Ception to further asthma control research
Drug Discovery News Placeholder Image

Out of left field

Merck KGaA to acquire Millipore for $7.2 billion
Drug Discovery News Placeholder Image

Multi-faceted deal

Abbott expands pipeline with $450 million Facet Biotech acquisition

Feature

Drug Discovery News Placeholder Image

AACR’s Capitol idea

American Association for Cancer Research’s annual conference for 2010 heads to the nation’s capital and offers some new features

Contract Services

Drug Discovery News Placeholder Image

Eyes on Europe

AMRI expands geographic footprint and market share across the pond with Excelsyn acquisition
Drug Discovery News Placeholder Image

They’re certifiable … in a good way

BioClinica teams with two additional CROs to strengthen its Certified Partner Program
Drug Discovery News Placeholder Image

Clinical research gets a boost

invivodata’s regulatory expertise enhances INC Research’s global service offering
Drug Discovery News Placeholder Image

French say ‘oui’ to U.K.’s NextPharma

Ministry of Research approves company as a contract research and development organization; French clients can now claim tax credits
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A black mosquito is shown on pink human skin against a blurred green backdrop.

Discovering deeper insights into malaria research

Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Three burgundy round and linear conformations of oligonucleotides are shown against a black background.

Accelerating RNA therapeutic testing with liver microphysiological platforms

Researchers can now study oligonucleotide delivery and efficacy in a system that models a real human liver.
A 3D-rendered illustration of a eukaryotic cell highlighting organelles such as the nucleus, endoplasmic reticulum, mitochondria, and cytoskeletal structures in pink and purple tones.

Shining light on the subcellular proteome

Discover how innovative proteomics tools help researchers peer into once inaccessible organelles, allowing for new targets for drug discovery and development.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue